In April 2025, the Company announced that the first patient had been dosed in Part 2a of the Phase 2 DENALI clinical trial ( NCT05128825) of azenosertib in patients with Cyclin E1+ platinum-resistant ...

India, soon to be the cardiovascular disease capital, faces rising heart attack rates, especially among women who experience them a decade earlier tha ...

BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today ...

Herpesviruses, which cause skin and genital infections, neonatal diseases, and meningitis, can successfully persist over a ...

Fast Track designation highlights potential of INX-315 to address unmet need for patients with recurrent advanced/metastatic cancer RESEARCH TRIANGLE PARK, N.C., April 29, 2025 (GLOBE NEWSWIRE ...

Choosing the right academic path after scoring a C+, C, or C- in KCSE can be challenging, but there are still many rewarding options available. In 2025, the best courses for C+, C or C minus students ...

Apple finally switched to the universal USB-C for its charging cable with the release of the iPhone 15, making it easier to charge and connect a bevy of electronics from a myriad of different ...

'ZDNET Recommends': What exactly does it mean? ZDNET's recommendations are based on many hours of testing, research, and comparison shopping. We gather data from the best available sources ...

Despite a 1 percent increase in 2024, U.S. birthrates remained in a historic slump, a trend that worries demographers and cultural critics. By Azeen Ghorayshi Births in the United States increased ...